Company
Valitor
Engineering a new generation of ophthalmic medicines
Also known as Valitor, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Berkeley, CA, United States
- Legal name
- Valitor, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Valitor is conquering limitations of established drug targets by leveraging its multivalent biopolymer technology to maximize benefits for patients.
Funding snapshot
- Total raised
- $10.2MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $8.4M2021-12-22
Funding rounds
- Round, 2021
- $8.4M2021-12-22, SEC form D sold, 8 investors
- Round, 2018
- $1.7M2018-09-20, SEC form D sold, 6 investors
Products
- Other
- VLTR-559
Loading relationship preview